Geneva Partners’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-28,502
Closed -$13.8M – 92
2026
Q2
$13.8M Buy
+28,502
New +$10.8M 3.68% 7
2020
Q3
– Sell
-31,285
Closed -$2.64M – 94
2020
Q2
$2.64M Buy
+31,285
New +$2.1M 1.85% 23

Other funds holding TER

Geneva Partners's TER Position: Q3 2026 in Review

Geneva Partners sold out of Teradyne (TER) in Q3 2026, closing a stake of 28,502 shares — an estimated $13.8M sold.

Geneva Partners first reported a position in TER in Q2 2020 and held it in 2 quarters. The position peaked at $13.8M in Q2 2026. 387 funds tracked by Wall St. Rank hold TER as of Q3 2026.

  • Geneva Partners reported no remaining Teradyne position as of Q3 2026 after selling out during the quarter.
  • Geneva Partners sold 28,502 Teradyne shares in Q3 2026, an estimated $13.8M.
  • Geneva Partners first reported a position in Teradyne in Q2 2020 and held it in 2 quarters.
  • Geneva Partners's Teradyne position peaked at $13.8M in Q2 2026.
  • 387 funds tracked by Wall St. Rank held Teradyne as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.